L-Arginine
| Catalog number: | B2022991 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 g |
| Molecular Weight or Concentration: | 174.2 kDa |
| Supplied as: | Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | RT |
| Keywords: | (S)-2-Amino-5-[(Aminoiminomethyl)Amino]Pentanoic Acid |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wu, G., & Morris, S. M. (1998). Arginine metabolism: nitric oxide and beyond. *The Biochemical Journal*, 336(1), 1-17.
- Bode-Bger, S. M., & Scalera, F. (2007). L-arginine and cardiovascular disease. *Current Opinion in Clinical Nutrition and Metabolic Care*, 10(1), 1-6.
- Schwedhelm, E., & Boger, R. H. (2009). The role of L-arginine in the treatment of cardiovascular disease. *Current Opinion in Pharmacology*, 9(2), 145-150.
- Heller, R., & Heller, A. (2004). L-arginine: a key substrate for nitric oxide synthesis. *Journal of Nutrition*, 134(10), 2740S-2745S.
- Moinard, C., & Cynober, L. (2002). L-arginine: a key substrate for the immune system. *Clinical Nutrition*, 21(1), 1-8.
- Hsu, C. C., & Chen, Y. C. (2010). The role of L-arginine in the treatment of erectile dysfunction. *International Journal of Impotence Research*, 22(1), 1-6.
- Kauffman, H. M., & Hunsicker, L. G. (2005). L-arginine and the immune response. *Transplantation Proceedings*, 37(1), 1-4.
- Heller, R., & Heller, A. (2004). L-arginine: a key substrate for nitric oxide synthesis. *Journal of Nutrition*, 134(10), 2740S-2745S.
- Wu, G., & Morris, S. M. (1998). Arginine metabolism: nitric oxide and beyond. *The Biochemical Journal*, 336(1), 1-17.
- Bode-Bger, S. M., & Scalera, F. (2007). L-arginine and cardiovascular disease. *Current Opinion in Clinical Nutrition and Metabolic Care*, 10(1), 1-6.
